1132940-31-8
1132940-31-8 structure
- Name: ABT-072 potassium trihydrate
- Chemical Name: ABT-072 potassium trihydrate
- CAS Number: 1132940-31-8
- Molecular Formula: C24H32KN3O8S
- Molecular Weight: 561.69
- Catalog: Signaling Pathways Anti-infection HCV
- Create Date: 2021-12-19 20:23:08
- Modify Date: 2025-08-27 17:56:04
-
ABT-072 (potassium trihydrate) is an orally active and potent non-nucleoside HCV NS5B polymerase inhibitor (HCV GT1a EC50=1 nM; HCV GT1b EC50=0.3 nM)[1][2][3].
| Name | ABT-072 potassium trihydrate |
|---|
| Description | ABT-072 (potassium trihydrate) is an orally active and potent non-nucleoside HCV NS5B polymerase inhibitor (HCV GT1a EC50=1 nM; HCV GT1b EC50=0.3 nM)[1][2][3]. |
|---|---|
| Related Catalog | |
| Target |
NS5B Polymerase[1] |
| In Vitro | ABT-072 (potassium trihydrate) is a non-nucleoside NS5B polymerase inhibitor with nanomolar potency in vitro against genotype 1a and 1b hepatitis C virus polymerases[1]. |
| In Vivo | ABT-072 (5 and/or 30 mg/kg; i.v. or p.o.) (potassium trihydrate) shows good PK properties[3]. ABT-072 (2.5 and/or 30 mg/kg; i.v. or p.o.) (potassium trihydrate) shows low plasma clearance and high oral bioavailability[3]. Animal Model: Rats[3] Dosage: 5 and/or 30 mg/kg (Pharmacokinetic Analysis) Administration: I.v. or p.o. Result: Showed good PK properties. Animal Model: Dog[3] Dosage: 2.5 or 30 mg/kg (Pharmacokinetic Analysis) Administration: I.v. or p.o. Result: Showed low plasma clearance and high oral bioavailability. |
| References |
| Molecular Formula | C24H32KN3O8S |
|---|---|
| Molecular Weight | 561.69 |